Cargando…
New-Onset Refractory Status Epilepticus (NORSE) as a Recurrence of Anti-Neuronal Nuclear Antibody 2 (ANNA-2) Encephalitis After Immune Checkpoint Inhibition Therapy
Paraneoplastic encephalitis from anti-neuronal nuclear antibody 2 (ANNA-2), usually associated with breast cancer, can cause seizures. We report a case of recurrent paraneoplastic encephalitis due to ANNA-2 presenting with new-onset refractory status epilepticus (NORSE) one month after receiving che...
Autores principales: | Pitter, Danielle, Mejico, Luis, Latorre, Julius G, Cuello-Oderiz, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324427/ https://www.ncbi.nlm.nih.gov/pubmed/34345555 http://dx.doi.org/10.7759/cureus.16074 |
Ejemplares similares
-
Editorial: Advances in diagnosing and treating new-onset refractory status epilepticus (NORSE)
por: Thomschewski, Aljoscha, et al.
Publicado: (2023) -
Limbic and new onset refractory tonic status epilepticus (NORSE) in anti-NMDAR encephalitis()
por: Kaplan, Peter W., et al.
Publicado: (2017) -
New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report
por: Dono, Fedele, et al.
Publicado: (2020) -
‘The great imitator’: Neurosyphilis and new-onset refractory status epilepticus (NORSE) syndrome
por: Kumari, Sonia, et al.
Publicado: (2015) -
Early clinical features of new-onset refractory status epilepticus (NORSE) in adults
por: Haanpää, Anna, et al.
Publicado: (2022)